2024 AUA Annual Meeting Previews : Episode 3
Feature
Video
2024 AUA preview: Dr. Elterman on key research in BPH
Author(s):
Dean S. Elterman, MD, MSc, FRCSC, highlights several studies in BPH being presented at the 2024 AUA Annual Meeting.
In this video, Dean S. Elterman, MD, MSc, FRCSC, highlights 4 studies in benign prostatic hyperplasia (BPH) that will be presented at the upcoming 2024 American Urological Association (AUA) Annual Meeting, which will take place on May 3 – 6 in San Antonio, Texas. Elterman is a urologist at the University of Toronto in Canada.
Elterman previewed the following abstracts:
- MP46-02 (Roehrborn et al): The Early Patient Experience Following Treatment with PUL and WVTT, Two Contemporary MISTs for BPH: Preliminary Results from the CLEAR Study
- MP06-15 (Elliott et al): The Optilume® Drug Coated Balloon for recurrent anterior urethral strictures: ROBUST III study 4-year interim results
- MP46-04 (Cerrato et al): Rezum for BPH: results from a large retrospective multicenter study
- MP27-01 (Gilling et al): 24-Month Outcomes from the ZEST Pilot studies of the Zenflow Spring System for the Treatment of Benign Prostatic Hyperplasia (BPH)
Related Videos
Related Content
